Counsyl Appoints SVP of Corporate Development and VP of Women’s Health Sales

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Counsyl,
a company that provides DNA testing and genetic counseling services,
today announced it has made two new strategic executive hires: Matthew
J. Meyer, who will serve as senior vice president, corporate
development, and Noah Nasser, who joins Counsyl as vice president,
women’s health sales.


Meyer will play a key role in shaping the next chapter for Counsyl as
the company evolves into a fully integrated diagnostic firm by pursuing
international partnerships and external growth opportunities. Nasser
will lead the women’s health sales team and will drive sales growth for
Counsyl’s women’s health offerings.

“Matt and Noah will play pivotal roles during our exciting new phase at
Counsyl, as we expand further into the clinical space and strengthen our
relationships with physicians,” said Ramji Srinivasan, co-founder and
CEO of Counsyl. “Their expertise closely aligns with Counsyl’s long-term
strategy and goals, and we’re glad to have them on board.”

Meyer joins Counsyl from CareDx, an early pioneer in the molecular
diagnostics field, where he served as chief business officer. He has
extensive experience working in therapeutics as well as diagnostics in a
range of commercial and corporate roles. Meyer is also an attorney who
worked at Pfizer and has served as general counsel at Cerimon
Pharmaceuticals and Draeger Medical Systems, in addition to commercial
roles at Allscripts and Novartis in Switzerland.

Nasser joins Counsyl from diagnostics company Althea, where he
commercialized testing for pharmacogenetics. Prior to Althea, Nasser was
the global sales leader for Verinata Health, an Illumina company. Before
the acquisition of the company by Illumina in 2013, Nasser was
Verinata’s vice president of sales and market development.

“I am delighted to be joining Counsyl and look forward to helping the
company grow its already impressive stable of testing services through
expansion into international markets and the addition of complementary
tests to its menu,” said Meyer.

“I’m thrilled to be joining a company that helps reproductive medicine
practitioners and patients make important health decisions,” said
Nasser. “I am eager to further drive the sales of Counsyl’s women’s
health products, and guide the sales team as we continue to expand into
clinical markets.”

About Counsyl

Counsyl is a company that provides DNA testing and genetic counseling
services. We’re committed to helping patients understand their DNA and
how it can inform important health decisions. Whether it’s starting a
family or evaluating risk for cancer, Counsyl’s DNA tests provide
patients with early awareness about genetic conditions, so they can live
informed and prepare for the future. Counsyl has screened more than
650,000 patients and served more than 10,000 health care professionals.
For more information, visit www.counsyl.com.

Contacts

Counsyl
Andrew Padgett, 415-381-4301
press@counsyl.com